Recurrent childhood lymphoblastic lymphoma
Clinical trials for Recurrent childhood lymphoblastic lymphoma explained in plain language.
Never miss a new study
Get alerted when new Recurrent childhood lymphoblastic lymphoma trials appear
Sign up with your email to follow new studies for Recurrent childhood lymphoblastic lymphoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a Tumor's own cells reveal the best drug for each child?
Disease control Recruiting nowThis trial explores whether testing a child's own tumor cells against a panel of approved drugs can help doctors choose a personalized treatment plan. It enrolls children and young adults up to age 21 with recurrent or refractory cancers, including leukemias, lymphomas, and solid…
Matched conditions: RECURRENT CHILDHOOD LYMPHOBLASTIC LYMPHOMA
Phase 1 • Sponsor: Florida International University • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New drug cocktail aims to tackle tough blood cancers
Disease control Recruiting nowThis phase II trial is testing a combination of six chemotherapy drugs (clofarabine, etoposide, cyclophosphamide, liposomal vincristine, dexamethasone, and bortezomib) in patients with acute lymphoblastic leukemia, lymphoblastic lymphoma, or related cancers that have come back or…
Matched conditions: RECURRENT CHILDHOOD LYMPHOBLASTIC LYMPHOMA
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC